Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obatoclax with Rituximab and Bendamustine in Indolent Non-Hodgkin's Lymphoma
NCT01238146Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Oct 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of obatoclax in B-cell non-Hodgkin lymphoma, sponsored by National Cancer Institute. Planned start Oct 2010; status: withdrawn.
02
Drugs
obatoclax
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT01238146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238146.